Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Intel Corporation (INTC) -- Ignore unavailable to you. Want to Upgrade?

To: semi_infinite who wrote (83237)	6/10/1999 10:57:00 PM
From: Tony Viola	Respond to of 186894

Ray, IBM's eight-way system is based on the Profusion chipset developed by Corollary, a company Intel acquired. Part of the Profusion package is the communications chips, developed by Compaq Computer. This is great news! The max number of CPUs in a tightly coupled Intel based SMP system has just doubled. And, IBM and Compaq, two love/hate companies with Intel are right in the middle of it. IBM will show its Netfinity 8500R with eight Xeon processors at the PC Expo conference in New York on June 21, said Jim Gargin, director of product marketing for the Netfinity line. "We're launching an all-out attack on the high end," Gargin said. IBM is launching an all-out attack on itself? Actually, IBM's strategy seems to have become something like that. They are offering products that represent each of the hot selling server product types, even if in a segment they end up with multiple products of their own. "We see the sweet spot as being between 16 and 32 nodes," a capability IBM expects to have in place during the first half of 2000, Gargin said. A node in these product lines had been up to four CPU chips (all Intel), now it's going to eight CPU chips. A sweet spot of 8X16 or 8X32, or more CPU chips for just one "footprint" is one heck of a lot of Xeons (or other Intel chips to come), and other supporting Intel hardware. IBM has become smart and gotten over the NIH thing. If you can't beat 'em, join 'em. Oh, by the way, I'm sure IBM will incorporate a lot of their industry leading RAS in these babies. I'm stoked! Tony